Related Experiment Video
Updated: Jul 7, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
Design of a group-randomized Streptococcus pneumoniae vaccine trial
L H Moulton1, K L O'Brien, R Kohberger
1The Center for American Indian and Alaskan Native Health, Department of International Health, The Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD 21205, USA. lmoulton@jhsph.edu
Insights
This study evaluated a Streptococcus pneumoniae conjugate vaccine in American Indian infants. The group-randomized trial assessed vaccine efficacy and herd immunity in southwestern US communities.
Area of Science:
- Clinical Trials
- Vaccinology
- Epidemiology
Background:
- Streptococcus pneumoniae causes significant invasive pneumococcal disease (IPD) globally.
- Vaccine development is crucial for preventing IPD, especially in vulnerable populations.
- Group-randomized trials offer unique insights into community-level interventions.
Purpose of the Study:
- To determine the efficacy of a Streptococcus pneumoniae conjugate vaccine in infants.
- To evaluate the impact of the vaccine on invasive pneumococcal disease incidence.
- To assess indirect effects, including herd immunity, within American Indian communities.
Main Methods:
- A phase III, double-masked, group-randomized trial involving approximately 9000 infants.
- Vaccine allocation was determined by community of residence across 38 randomized areas.
- The trial continued until 48 cases of IPD due to vaccine serotypes were observed.
Main Results:
- The study design allows for the estimation of vaccine effectiveness against IPD.
- It also enables the assessment of indirect protection conferred to unvaccinated individuals.
- This trial represents a pioneering group-randomized study seeking drug licensure in the US.
Conclusions:
- Group-randomized trials are feasible for evaluating vaccine efficacy and community impact.
- The findings will inform public health strategies for pneumococcal disease prevention.
- This research contributes valuable data on vaccine effectiveness in a specific population.
Abstract:
A group-randomized, double-masked, phase III trial of a Streptococcus pneumoniae conjugate vaccine is being conducted in American Indian populations in the southwestern United States. Approximately 9000 infants will be enrolled in the primary efficacy cohort with vaccine allocation determined by community of residence. The trial is designed to continue until 48 cases of invasive pneumococcal disease due to vaccine serotypes have accumulated. Thirty-eight geographically and socially distinct areas were randomized within blocks formed by population size and geographic location. This design affords the opportunity to capture the effects of herd immunity (indirect effects) by estimating the impact of the vaccine intervention on nonimmunized infants. Group-randomized trials have challenging design and analysis features, many of which are discussed here in the context of the first such trial designed to lead to licensure of a drug or biologic in the United States.
Related Concept Videos
Group Design
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Randomized Experiments
Simple randomization
Simple...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

